tolebrutinib
sanofi
['tolebrutinib', 'sanofi']
new two- time efficacity and safety data for tolebrutinib, sanofi s investigational, brain- penetrant and bioactive btk asset, to be presented at ectrims 2022 
THE PHARMA DATA is an Information-Centric Website focused mainly on latest Pharma News, Press Release, Industry related updates, Events and Conferences.